BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

11:48 AM
Apr 02, 2018
 |  BC Extra  |  Financial News

Antibiotic play Macrolide raises $20M, names Karande CEO

Macrolide Pharmaceuticals Inc. (Watertown, Mass.) raised $20 million on Monday in a venture round led by existing investors Advent Life Sciences, Gurnet Point Capital, Novartis Venture Fund, Roche Ventures and SR One. The antibiotic company also hired Mahesh Karande as president and CEO. He was VP and general manager at Intarcia Therapeutics Inc. (Boston, Mass.).


Read the full 260 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >